Obsessive-Compulsive Disorder in PANS/PANDAS in Children: In Search of a Qualified Treatment-A Systematic Review and Metanalysis.

ENT OCD PANDAS adenotonsillectomy behavioral disorders infection orobuccal disorders

Journal

Children (Basel, Switzerland)
ISSN: 2227-9067
Titre abrégé: Children (Basel)
Pays: Switzerland
ID NLM: 101648936

Informations de publication

Date de publication:
26 Jan 2022
Historique:
received: 03 11 2021
accepted: 18 01 2022
entrez: 25 2 2022
pubmed: 26 2 2022
medline: 26 2 2022
Statut: epublish

Résumé

Several treatment options have been proposed for pediatric acute-onset neuropsychiatric syndrome/pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANS/PANDAS). Still, no clear therapeutic protocol has been recognized to prevent these neuropsychiatric diseases. The study aims to report on the literature evidence and different treatment strategies related to these disorders. We analyzed the last 20 years' English language literature and performed a comprehensive review of the PANS/PANDAS treatment, including studies reporting OCD outcomes post-treatment follow-up. We covered 11 articles in our systematic literature review for a total of 473 patients, of which four studies included 129 surgical subjects and seven papers with 326 medically treated patients. Pooled outcomes analysis, surgical and medical treatment reported an OCD reduction, but no statistical significance was obtained ( Surgical therapy in selected patients can lead to promising results, although further evidence is needed. On the other hand, the role of medical therapy remains controversial, often due to the lack of univocal curative protocols and variable responses depending on the drug used and the timing of administration. Therefore, further investigations are necessary to clarify the most appropriate therapeutic procedure.

Sections du résumé

BACKGROUND BACKGROUND
Several treatment options have been proposed for pediatric acute-onset neuropsychiatric syndrome/pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANS/PANDAS). Still, no clear therapeutic protocol has been recognized to prevent these neuropsychiatric diseases. The study aims to report on the literature evidence and different treatment strategies related to these disorders.
METHODS METHODS
We analyzed the last 20 years' English language literature and performed a comprehensive review of the PANS/PANDAS treatment, including studies reporting OCD outcomes post-treatment follow-up.
RESULTS RESULTS
We covered 11 articles in our systematic literature review for a total of 473 patients, of which four studies included 129 surgical subjects and seven papers with 326 medically treated patients. Pooled outcomes analysis, surgical and medical treatment reported an OCD reduction, but no statistical significance was obtained (
CONCLUSIONS CONCLUSIONS
Surgical therapy in selected patients can lead to promising results, although further evidence is needed. On the other hand, the role of medical therapy remains controversial, often due to the lack of univocal curative protocols and variable responses depending on the drug used and the timing of administration. Therefore, further investigations are necessary to clarify the most appropriate therapeutic procedure.

Identifiants

pubmed: 35204876
pii: children9020155
doi: 10.3390/children9020155
pmc: PMC8869780
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

J Immunol. 2007 Jun 1;178(11):7412-21
pubmed: 17513792
JAMA Otolaryngol Head Neck Surg. 2015 Mar;141(3):272-5
pubmed: 25569020
Ann Intern Med. 2011 Oct 18;155(8):529-36
pubmed: 22007046
Int J Pediatr Otorhinolaryngol. 2016 Oct;89:149-53
pubmed: 27619047
J Can Chiropr Assoc. 2012 Sep;56(3):167-71
pubmed: 22997465
Int J Immunopathol Pharmacol. 2014 Jul-Sep;27(3):371-8
pubmed: 25280028
J Child Adolesc Psychopharmacol. 2017 Sep;27(7):566-573
pubmed: 28722481
J Child Adolesc Psychopharmacol. 2018 Mar;28(2):92-103
pubmed: 28832181
J Am Acad Child Adolesc Psychiatry. 2016 Oct;55(10):860-867.e2
pubmed: 27663941
J Child Adolesc Psychopharmacol. 2019 Oct;29(8):634-641
pubmed: 31009235
J Child Adolesc Psychopharmacol. 2019 May;29(4):305-312
pubmed: 30724577
Am J Otolaryngol. 2021 Jul-Aug;42(4):102963
pubmed: 33706120
J Child Adolesc Psychopharmacol. 2017 Sep;27(7):652-659
pubmed: 28696783
Tidsskr Nor Laegeforen. 1993 Oct 20;113(25):3162-3
pubmed: 8273044
J Child Adolesc Psychopharmacol. 2015 May;25(4):337-43
pubmed: 25978743
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):3-13
pubmed: 25325534
Psychiatr Clin North Am. 1998 Sep;21(3):693-703, viii
pubmed: 9774805
Lancet. 1999 Oct 2;354(9185):1153-8
pubmed: 10513708
J Am Acad Child Adolesc Psychiatry. 2006 Oct;45(10):1171-8
pubmed: 17003662
Pediatr Infect Dis J. 2013 Aug;32(8):834-8
pubmed: 23518825
Neurol Neurochir Pol. 2019;53(5):315-316
pubmed: 31664709
Paediatr Child Health. 2019 May;24(2):85-91
pubmed: 30996598
J Pediatr Pharmacol Ther. 2020 Jan-Feb;25(1):61-63
pubmed: 31897077
Lancet Child Adolesc Health. 2021 Jun;5(6):e19-e21
pubmed: 33961798
J Child Adolesc Psychopharmacol. 2017 Sep;27(7):640-651
pubmed: 28358599
Am J Psychiatry. 1998 Feb;155(2):264-71
pubmed: 9464208
Int J Otolaryngol. 2018 Feb 21;2018:2681304
pubmed: 29675045
Arch Pediatr Adolesc Med. 2002 Apr;156(4):356-61
pubmed: 11929370
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
J Neuroimmunol. 2006 Oct;179(1-2):173-9
pubmed: 16875742
Stat Med. 2014 Jul 20;33(16):2701-17
pubmed: 24903142
Biol Psychiatry. 2005 Apr 1;57(7):788-92
pubmed: 15820236
J Child Adolesc Psychopharmacol. 2017 Sep;27(7):619-628
pubmed: 28696786
J Neuroimmunol. 2000 Nov 1;111(1-2):195-202
pubmed: 11063838
J Child Neurol. 2000 Dec;15(12):791-6
pubmed: 11198493
J Clin Invest. 2016 Jan;126(1):303-17
pubmed: 26657857
J Child Adolesc Psychopharmacol. 2017 Sep;27(7):629-639
pubmed: 28714753
J Child Neurol. 2008 Mar;23(3):338-40
pubmed: 18079308
J Child Adolesc Psychopharmacol. 2015 Feb;25(1):70-5
pubmed: 25658452
Neurosci Biobehav Rev. 2018 Mar;86:51-65
pubmed: 29309797
Eur Rev Med Pharmacol Sci. 2019 May;23(10):4110-4117
pubmed: 31173280

Auteurs

Salvatore Cocuzza (S)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Antonino Maniaci (A)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Ignazio La Mantia (I)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Francesco Nocera (F)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Daniela Caruso (D)

Unit of Clinical Pediatrics, A.O.U. "Policlinico", P.O. "G. Rodolico", University of Catania, 95123 Catania, Italy.

Sebastiano Caruso (S)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Giannicola Iannella (G)

Department of Head-Neck Surgery, Otolaryngology, Head-Neck and Oral Surgery Unit, Morgagni Pierantoni Hospital, 47121 Forlì, Italy.
Department of Sensory Organs, Sapienza University of Rome, 00194 Rome, Italy.

Claudio Vicini (C)

Department of Head-Neck Surgery, Otolaryngology, Head-Neck and Oral Surgery Unit, Morgagni Pierantoni Hospital, 47121 Forlì, Italy.

Elio Privitera (E)

Department of Medical and Surgical Sciences and Advanced Technologies "GF Ingrassia", ENT Section, University of Catania, 95123 Catania, Italy.

Jerome Rene Lechien (JR)

Department of Human Anatomy and Experimental Oncology, Faculty of Medicine, UMONS Research Institute for Health Sciences and Technology, University of Mons (UMons), 7000 Mons, Belgium.

Piero Pavone (P)

Unit of Clinical Pediatrics, A.O.U. "Policlinico", P.O. "G. Rodolico", University of Catania, 95123 Catania, Italy.

Classifications MeSH